Vivimed Labs Ltd. — Major Shareholding Notification 2020

Mar 10, 2020

Date: 10th March, 2020

To
BSE Limited,	National Stock Exchange of India Limited
Phiroze JeeJeebhoy Towers,	Exchange Plaza, Plot No.C/, G Block,
Dalal Street,	Bandra Kurla Complex, Bandra (East)
Mumbai-400001	Mumbai-400051

Stock Code: 532660

Stock Code: VIVIMEDLAB

Dear Sir/Madam,

Target Company: Vivimed Labs Limited

Re:1. Disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

We have enclosed the following for your kind perusal/records:

1. Intimation as regards to Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in connection with the Purchase of equity shares ofVivimed Labs Limited as a promoter of the Company.

With Best R&: SANDEEP V ARAL W AR

Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

NameoftheTargetCompany(TC)	VivimedLabsLimited
Name(s)oftheacquirerandPersonsActinginConcert(PAC)withtheacquirer	SANDEEPVARALWAR
WhethertheacquirerbelongstoPromoter/Promotergroup	Yes
Name(s)oftheStockExchange(s)wherethesharesofTCareListed	BombayStockExchangeLimitedNationalStockExchangeofIndiaLimited
Detailsoftheacquisitionasfollows	Number	%w.r.t.totalshare/votingcapitalwhereverapplicable(*)	%W.r.t.totaldilutedshare/votingcapitaloftheTC(**)
Beforetheacquisitionunderconsideration,holdingof:
a)Sharescarryingvotingrights	14,69,765	1.772	1.720
b)SharesinthenatureofencumbranceI (pledge/lien!	-	-	-
c)Votingrights(VR)otherwisethanbyshares	-	-	-
d)Warrants/convertiblesecurities/anyotherinstrumentthatentitlestheacquirer	-	-	-
e)Total(a+b+c+d)	14,69,765	1.772	1.720
Detailsofacquisition
a)Sharescarryingvotingrightsacquired	92,266	0.111	0.108
b)VRsacquired/soldotherwisethanbyshares	-	-	-
c)Warrants/convertiblesecurities/anyotherinstrumentthatentitlestheacquirertoreceivesharescarryingvotingrightsintheTC(specifyholdingineachcategory)acquired/sold	-	-	-
d)Sharesencumbered/invoked/releasedbytheacquirer	-	-	-
e)Total(a+b+c+/-d)	92,266	0.111	0.108

Aftertheacquisitionholdingof:
a)Sharescarryingvotingrights	15,62,031	1.883	1.828
b)Sharesencumberedwiththeacquirer	-	-	-
c)VRsotherwisethanbyshares	-	-	-
d)Warrants/convertiblesecurities/anyotherinstrumentthatentitlestheacquirertoreceivesharescarryingvotingrightsintheTC(specifyholdingineachcategory)afteracquisition	-	-	-
e)Total(a+b+c+d)	15,62,031	1.883	1.828
tModeofacquisition(e.g.openmarketIoffmarketfpublicissuerightsissue,'preferentialallotmentsetransferI-interetc).	Openmarket
Dateofacquisition,Ls-ale ofshares,'VRordateofreceiptofintimationofallotmentofshares,whicheverisapplicable	06.03.2020
Equitysharecapital/totalvotingcapitaloftheTCbeforethesaidacquisition/sale	82913915equitysharesofRs.2/-each
Equitysharecapital!totalvotingcapitaloftheTCafterthesaidacquisitionf-sale	82913915equitysharesofRs.2/-each
Totaldilutedshare/votingcapitaloftheTCafterthesaidacquisition	85413915equitysharesofRs.2/-each

(*) Total share capital! voting capital to be taken as per the latest filing done by the company to the Stock Exchanges.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

SANDEEPVARALWAR

Place: Hyderabad Date: 10.03.2020